Fungal Fusion ERADICATION Solution
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Yes — there is an active recall. 4 ongoing FDA recalls mention Miconazole (18 total). Check the affected lots below.
Most common reason: Chemical / undeclared (8 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Miconazole. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list.
Chemical Contamination; presence of benzene.
CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.
Chemical Contamination: presence of benzene
Chemical Contamination: presence of benzene
Chemical Contamination: presence of benzene
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
CGMP Deviations
Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for the cure of most jock itch" rather than "use for the cure of most athlete's foot".
Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.